ReviewClinical microbiology reviews2015
Leprosy in the 21st century.
Review in Clinical microbiology reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
107 citing papers in PubMed, 5 syntheses or guidelines pooled it, 246 citations in OpenAlex.
- Prevalence of paucibacillary cases of leprosy in Brazil: a 20-year systematic review and meta-analysis.Frontiers in medicine · 2024Pooled it
- Stigma towards leprosy across seven life domains in Indonesia: a qualitative systematic review.BMJ open · 2022Pooled it
- Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.International journal of molecular sciences · 2022Pooled it
- Experiences of living with leprosy: A systematic review and qualitative evidence synthesis.PLoS neglected tropical diseases · 2022Pooled it
- Systematic Review of Survival Analysis in Leprosy Studies-Including the Following Outcomes: Relapse, Impairment of Nerve Function, Reactions and Physical Disability.International journal of environmental research and public health · 2022Pooled it
- miRNome Expression Analysis Reveals New Players on Leprosy Immune Physiopathology.Frontiers in immunology · 2018Trial
- Surveillance data and progress assessment of the targets of the WHO Global Leprosy Strategy 2016-2020: A retrospective registry-based analysis in Ghana.PLoS neglected tropical diseases · 2026Article
- Article
- Involvement of African patient populations in clinical trials on leprosy: a scoping review.Tropical medicine and health · 2026Review
- Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy.Dermatology online journal · 2026Article
- Leprosy research registry a global perspective: Need of hour for a newer vision in India towards zero leprosy.Indian journal of pharmacology · 2025Article
- Erythema Nodosum Leprosum in a Patient with Borderline Lepromatous Leprosy: A Case Report.Infectious disease reports · 2025Article
- Review
- Unraveling Drug Resistance inInternational journal of microbiology · 2025Review
- Leprosy-Presenting as Rheumatoid Arthritis Misleading the Correct Diagnosis.Clinical case reports · 2025Article
- Art in Science: Unclean, Unclean.Clinical orthopaedics and related research · 2025Article
- Exploring the experiences of leprosy stigma among patients and healthcare workers in Norte de Santander, Colombia.PLOS global public health · 2025Article
- Socioeconomic determinants of the leprosy risk in Yunnan Province, China: a county-level spatiotemporal study.Frontiers in public health · 2025Article
- Lepromatous leprosy in Bronze Age Oman: micro-CT provides tools for paleopathology in fragmentary and commingled assemblages.Frontiers in medicine · 2025Article
- Spatial associations of Hansen's disease and schistosomiasis in endemic regions of Minas Gerais, Brazil.PLoS neglected tropical diseases · 2024Article
47 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite significant improvements in leprosy (Hansen's disease) treatment and outlook for patients since the introduction of multidrug therapy (MDT) 3 decades ago, the global incidence remains high, and patients often have long-term complications associated with the disease. In this article, we discuss recent findings related to genetics, susceptibility, and disease reservoirs and the implications of these findings for Hansen's disease control and health outcomes for patients. We describe the continued difficulties associated with treatment of inflammatory episodes known as "leprosy reactions," which cause much of the disability associated with the disease and can affect people for many years after MDT is complete. We also discuss some of the contemporary challenges for physicians and patients, including international and internal migration of people affected by the disease. We suggest some important areas of focus for future Hansen's disease research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.